[{"address1": "2450 Holcombe Blvd.", "address2": "Suite X", "city": "Houston", "state": "TX", "zip": "77021", "country": "United States", "phone": "(713) 913-5608", "website": "https://www.salariuspharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Salarius Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company that focuses on developing treatments for cancers with unmet medical need. Its lead candidate is Seclidemstat (SP-2577), a small molecular inhibitor which is in Phase I/II clinical trial for the treatment of advanced solid tumors, as well as Ewing sarcoma. The company also offers SP-3164, a small molecular protein degrader for the treatment of hematological and solid tumors. It has a strategic partnership with The University of Utah Research Foundation for the exclusive license with respect to patent rights protecting SP-2577 and related compounds and Cancer Prevention and Research Institute of Texas for product development activities. The company is based in Houston, Texas.", "fullTimeEmployees": 2, "companyOfficers": [{"maxAge": 1, "name": "Mr. David J. Arthur M.B.A.", "age": 61, "title": "CEO, President & Director", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 726185, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark J. Rosenblum CPA", "age": 71, "title": "Executive VP of Finance & CFO", "yearBorn": 1953, "fiscalYear": 2024, "totalPay": 339050, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.4527, "open": 0.443, "dayLow": 0.43, "dayHigh": 0.4619, "regularMarketPreviousClose": 0.4527, "regularMarketOpen": 0.443, "regularMarketDayLow": 0.43, "regularMarketDayHigh": 0.4619, "payoutRatio": 0.0, "beta": 0.452, "forwardPE": -0.05035987, "volume": 603423, "regularMarketVolume": 603423, "averageVolume": 3227754, "averageVolume10days": 737680, "averageDailyVolume10Day": 737680, "bid": 0.3195, "ask": 0.5591, "bidSize": 2, "askSize": 2, "marketCap": 3530733, "fiftyTwoWeekLow": 0.43, "fiftyTwoWeekHigh": 7.2, "fiftyDayAverage": 0.75184, "twoHundredDayAverage": 1.175325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2735849, "profitMargins": 0.0, "floatShares": 7606984, "sharesOutstanding": 7645590, "sharesShort": 53573, "sharesShortPriorMonth": 47053, "sharesShortPreviousMonthDate": 1751241600, "dateShortInterest": 1753920000, "sharesPercentSharesOut": 0.105100006, "heldPercentInsiders": 0.00475, "heldPercentInstitutions": 0.025150001, "shortRatio": 0.16, "shortPercentOfFloat": 0.105299994, "impliedSharesOutstanding": 7645590, "bookValue": -0.39, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -5103412, "trailingEps": -23.7, "forwardEps": -9.17, "lastSplitFactor": "1:8", "lastSplitDate": 1718582400, "enterpriseToEbitda": -0.482, "52WeekChange": -0.75684214, "SandP52WeekChange": 0.15005577, "quoteType": "EQUITY", "currentPrice": 0.4618, "recommendationKey": "none", "totalCash": 794886, "totalCashPerShare": 0.104, "ebitda": -5675021, "totalDebt": 0, "quickRatio": 0.358, "currentRatio": 0.612, "returnOnAssets": -1.43519, "returnOnEquity": -6.60367, "freeCashflow": -2657078, "operatingCashflow": -4143201, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SLRX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1755301293, "regularMarketTime": 1755288001, "exchange": "NCM", "messageBoardId": "finmb_330031056", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "fiftyTwoWeekChangePercent": -75.68421, "dividendDate": 1563753600, "earningsTimestampStart": 1754596800, "earningsTimestampEnd": 1754942400, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -23.7, "epsForward": -9.17, "fiftyDayAverageChange": -0.29004, "fiftyDayAverageChangePercent": -0.38577354, "twoHundredDayAverageChange": -0.71352506, "twoHundredDayAverageChangePercent": -0.60708743, "priceToBook": -1.1841027, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "postMarketChangePercent": -0.931139, "postMarketPrice": 0.4575, "postMarketChange": -0.0043, "regularMarketChange": 0.00910002, "regularMarketDayRange": "0.43 - 0.4619", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3227754, "fiftyTwoWeekLowChange": 0.0318, "fiftyTwoWeekLowChangePercent": 0.073953494, "fiftyTwoWeekRange": "0.43 - 7.2", "fiftyTwoWeekHighChange": -6.7381997, "fiftyTwoWeekHighChangePercent": -0.9358611, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1422541800000, "shortName": "Salarius Pharmaceuticals, Inc.", "longName": "Salarius Pharmaceuticals, Inc.", "marketState": "CLOSED", "regularMarketChangePercent": 2.01017, "regularMarketPrice": 0.4618, "displayName": "Salarius Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-08-16"}]